127 



I lat'la on an additional matting with Dr. Abood and 

 [h't. S&fldars, Saaaan, and Chavdarian during Dr. Abood' s last 

 visit. I foufid tht discujsions tc b« usaful and fait t.HaC 

 Dr. Abood was doinj loaa vary intarajting work which can 

 ultisiataly b« of banafit to Philip Morris. I also utilizad 

 Dr. Abood as a consultant during that visit and ht oaut joaa 

 good sug|«stioas and I thought tha tiaa was wall spent. 



la suaaaT7, tha aicotina racaptor program at tha 

 Univarslty of Rochastar is an Intagral part of our ovarall 

 aicotlat proft«*- ^* combination of basic rasaarch on tha ■_ 

 pharaaeolofy of tha nicotina racaptor coabinad with tha 

 capability to scraan nicotina analogs for CNS activity 

 coBplanants our intamal synthatie and bahavioral afforts 

 ia tha nicotina proyram. Tha program is Justlflad ia my viaw 

 °«s a dafansiva rasponsa to tha anti-saoking foreas criticisms 

 of nicotina and also as fundamental rasaarch into tha natura 

 of our product and how it af facts our customors, tha smokars. 

 This antira program involva? complax tachnological pro"bla«i 

 and tha banafits to ba darlvad from tha program will not ba 

 raalixad iaaadiataly. Indaad tha banafits will nacossarily . 

 b« of a long-tara natura and may hava diract baaring on our 

 markat position in a 10-lS yaar tiaa framm. Howavar, if wa 

 do not hava tha basic rasaarch rasults this program will 

 provida wa will not bt ia a position to raspond if and whan 

 tha prassuras to changt do occur. 



JlC/mro <V 



cc: Dr. T. S. Osdant ^^ 



i 



<P 



^"^ 



f^ 



I 



OB 

 (A 



CI 



'T^ 





<i II ■ >-A*«fa 



